Instil Bio (TIL) Financial Statements

375 Followers

Instil Bio Financial Overview

Instil Bio's market cap is currently $54.32M. The company's EPS TTM is $-10.78; its P/E ratio is -2.28; Instil Bio is scheduled to report earnings on May 7, 2026, and the estimated EPS forecast is $-0.59. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Mar 23	Dec 21
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -534.00K	$ 0.00	$ 0.00	$ -5.99M	$ 0.00
Operating Income	$ -52.91M	$ -73.54M	$ -159.17M	$ -206.17M	$ -155.56M
EBITDA	$ -52.37M	$ -62.53M	$ -147.12M	$ -217.38M	$ -152.51M
Net Income	$ -71.37M	$ -74.14M	$ -156.09M	$ -223.18M	$ -156.79M
Balance Sheet
Cash & Short-Term Investments	$ 76.13M	$ 113.31M	$ 150.36M	$ 260.92M	$ 454.10M
Total Assets	$ 203.52M	$ 263.57M	$ 325.63M	$ 482.13M	$ 609.98M
Total Debt	$ 85.18M	$ 86.89M	$ 86.05M	$ 79.90M	$ 0.00
Net Debt	$ 78.54M	$ 78.08M	$ 76.86M	$ 36.19M	$ -37.59M
Total Liabilities	$ 89.66M	$ 94.13M	$ 99.80M	$ 118.52M	$ 54.78M
Stockholders' Equity	$ 113.87M	$ 169.44M	$ 225.83M	$ 363.61M	$ 555.20M
Cash Flow
Free Cash Flow	$ -36.62M	$ -65.70M	$ -102.69M	$ -264.75M	$ -179.97M
Operating Cash Flow	$ -36.62M	$ -55.70M	$ -82.03M	$ -180.16M	$ -122.14M
Investing Cash Flow	$ 25.48M	$ 53.97M	$ 41.13M	$ 114.54M	$ -474.40M
Financing Cash Flow	$ 7.29M	$ 1.75M	$ 8.08M	$ 71.89M	$ 393.16M

Currency in USD

Instil Bio Earnings and Revenue History

Income Statement >

Instil Bio Debt to Assets

Balance Sheet >

Instil Bio Cash Flow

Cash Flow >

Instil Bio Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >